-
Randomized controlled trial of 1Hz SMA rTMS + gait training for Freezing of Gait
-
Randomized, placebo-controlled, double-blind, two-period cross-over study to evaluate the safety, tolerability, and efficacy of a novel treatment combination for levodopa induced dyskinesia in Parkinson’s Disease (BUS-PD)
-
Rapid improvement in dystonia after pallidal deep brain stimulation in a patient with myoclonus-dystonia syndrome: A case report
-
Rapid Picture Naming in Parkinson’s Disease Using the Mobile Universal Lexicon Evaluation System (MULES) Test
-
Rapidly onset progressive generalised dystonia parkinsonism in a young Indian male with rare FBXO 7 genetic mutation
-
Rapidly progressive cognitive decline and hemi-dystonia due to anti-neuronal surface antibodies
-
Rare causes of Opsoclonus Myoclonus Ataxia Syndrome
-
Rare manifestation of CNS Lupus: Parkinsonism
-
RDP is associated with bulbar and limb weakness: broadening the phenotype of ATP1A3+ Rapid-Onset Dystonia-Parkinsonism (RDP)
-
Re-emergent tremor provocation
-
Re-emerging Neuroleptic Malignant Syndrome (NMS) without Re-introduced Neuroleptic in a Schizophrenia Patient: a Case Report
-
Real World Clinical Outcomes Using a Novel Directional Lead from a Multicenter Registry of Deep Brain Stimulation for Parkinson’s Disease
-
Real-life gait performance as a marker for motor fluctuations: the Parkinson@home Validation study
-
Reconstructing the history of Machado-Joseph disease
-
Reduced interhemispheric and premotor-motor connectivity during handwriting in patients with writer’s cramp
-
Reducing Ataxic Side Effects from VIM DBS Implantation in Essential Tremor: Advantages of Directional Stimulation
-
Regardless of impaired renal function, negative myoclonus can be induced by gabapetin and pregabalin
-
Regional subcortical volumes predict gait decline in early Parkinson’s disease
-
Registration Algorithm of DBS Preoperative Image and ICBM-152 Atlas
-
Relating web-based-visuo-perception to cognition and genetic variability in Parkinson’s disease: interim report
-
Relations of clinical symptoms with dopamine transporter imaging in untreated Parkinson’s disease
-
Relationship between cognitive performance and mobility in Parkinson’s disease
-
Relationship between cognitive performance and mobility in patients with Parkinson´s disease: A cross-sectional study
-
Relationship between daily physical activity measured by a triaxial accelerometer and motor symptoms in patients with Parkinson’s disease
-
Relationship between eye movements during natural reading and basic oculomotor tasks in PD
-
Relationship between functional exercise capacity and balance in patients with idiopathic Parkinson’s disease
-
Relationship Between Handgrip and Functional Mobility in a Brazilian Parkinsonian Elderly Population
-
Relationship between intestinal bacteria, bacterial metabolites and residual pesticides in Parkinson’s disease
-
Relationship between non-motor symptoms, medications and sleep interruptions in patients with Parkinson’s disease
-
Relationship between pain and autonomic symptoms in Parkinson’s Disease: a double-center, cross-sectional, observational study.
-
Relationship between parkinsonism and upper extremity function in patients with Parkinson’s disease
-
Relationship between Progressive Supranuclear Palsy and Caregiver Burden
-
Relationship between RBD and olfactory disorder, clinical symptoms in Parkinson’s disease
-
Relationship between restless legs syndrome and various factors in pregnancy
-
Relationship between serum uric acid and the pattern of striatal dopamine depletion in De Novo Parkinson’s disease
-
Relationship between striatal dopamine depletion and various non-motor symptoms in non-demented patients with Parkinson’s disease: a pilot study
-
Relationship between symptoms and regional density of metabotropic glutamate receptors subtype 1 measured with 11C-ITMM PET in de novo Parkinson’s disease
-
Relationship of cognitive processing speed with postural stability in non-demented Parkinson’s disease patients
-
Relationships of gender, care models, and neuropsychiatric symptoms in Parkinson’s disease
-
Relative Preservation of Serotonergic Function Increases Response to Treatment in Early PD
-
Reliability and Validity of Modified Four Square Step Test (mFSST) Performance in Individuals with Parkinson’s Disease.
-
Reliability, feasibility and validity of a novel digital monitoring platform assessing cognitive and motor symptoms in people with Stage I and II Huntington’s disease (HD)
-
REM density in isolated REM sleep without atonia
-
REM sleep behavior disorder and REM sleep without atonia is a progression marker in Parkinson’s disease: a report from the DeNoPa cohort
-
Repetitive transcranial magnetic stimulation (rTMS) for the treatment of pain in Parkinson’s Disease – an open-label study
-
Repetitive transcranial magnetic stimulation can improve anxiety in Parkinson’s disease: a randomized, double-blind and controlled trial
-
Repetitive transcranial magnetic stimulation does not improve the sequence effect in freezing of gait
-
Research on the modifier gene of Hereditary spinocerebellar ataxia type 2
-
Respiratory Function and Functional Decline in Spinocerebellar Ataxia Type 2
-
Resting state functional connectivity changes in dystonia
-
Resting state Functional Connectivity differences in Pediatric Patients with Tourette syndrome and Obsessive-compulsive disorder
-
Resting-state EEG functional connectivity in Parkinson’s disease
-
Resting-state EEG spectral power in Parkinson’s disease
-
Resting-State fMRI in Essential Tremor after MRgFUS treatment
-
Restless Genital Syndrome in a patient with Dementia with Lewy Body
-
Restless Leg Syndrome In Men: Examination Of Early Non-Motor Clinical Signs Of Parkinson’s Disease
-
Restless leg syndrome in Neuro-Behcet’s and Behcet’s disease
-
Restless legs syndrome in a patient with hereditary hemochromatosis
-
Restoring AADC enzyme synthesis in AADC deficiency: MRI-Guided Delivery of AAV2-hAADC Gene Therapy to the Midbrain
-
Results of community pharmacist-led structured medication reviews in Parkinson’s Disease
-
Retinal layer thinning in de novo Parkinson’s disease
-
Retinal thickness and microvascular pattern in early Parkinson’s disease.
-
Retronasal olfactory function in Parkinson’s disease
-
Retrospective analysis of hospitalized Parkinson ‘s disease patients from 2002 to 2014 in Suzhou district
-
Reverse phenotyping of a 3.3Mb loss of 8p11.21p11.1, including SLC20A2, lead to a diagnosis of primary familial brain calcification
-
Reviewing the clinical and mutational spectrum of SLC20A2, PDGFB, PDGFRB, XPR1 and MYORG mutations in Primary Familial Brain Calcification (PFBC) for MDSGene
-
Rhythmic disorders in idiopathic RBD: a potential new marker for future PD?
-
RimbotulinumtoxinB in the treatment of adult sialorrhea
-
Risk of developing the Parkinson’s disease against the background of diabetes mellitus type 2.
-
Risk of Parkinson’s in idiopathic anosmia
-
Risk Thresholds of Levodopa Dose for Dyskinesia in Chinese Patients with Parkinson’s Disease: A Pilot Study
-
Rivastigmine for visual hallucinations in Parkinson’s disease
-
RNA binding protein mediated regulation of striatal transcriptome in Parkinson’s disease.
-
Role of Alzheimer’s Disease Genetic Risk Variant rs9331896 in Cognitive Decline in Parkinson’s Disease
-
Role of APOE ε4 status and Sex on Somatosensory Integration and Dual-Task Cost in Parkinson’s disease
-
Role of clinical neuroimaging in X-linked dystonia-parkinsonism
-
Role of microRNA-153 and -223 in Parkinson disease
-
Role of pallidotomy in secondary dystonia in pediatric patients
-
rTMS-induced effects on Functional Tremor: a randomized, double-blind, controlled study
2019 International Congress
September 22-26, 2019. Nice, France.